Recently, public and private providers within two-tier healthcare markets have engaged in a fierce competition for patients, which is significantly influenced by patients' multifaceted sensitivities to delays and payments, particularly when patients' potential balking is considered. However,...

Background As the number of randomized clinical trials (RCTs) demonstrating the survival benefits of combination therapies in previously treated multiple myeloma (MM) patients increases, it is essential to determine the most cost- effective treatment through robust economic evaluation. This...

In this booklet, we provide an overview of the 24 ERNs and celebrate their achievements to the rare disease agenda, to actively communicate on the Commission's actions and decisions and explain the benefits and opportunities stemming from our work. The overall outlook emerging from reading this...

The EU's action on rare diseases strives to improve access to knowledge, diagnosis, and treatment of patients with rare diseases through funding research on rare diseases and newborn screening, making available dedicated tools, such as the telemedicine tool, pooling of resources and cooperation.

In this booklet, we provide an overview of the 24 ERNs and celebrate their achievements to the rare disease agenda, to actively communicate on the Commission's actions and decisions and explain the benefits and opportunities stemming from our work. The overall outlook emerging from reading this...

The EU's action on rare diseases strives to improve access to knowledge, diagnosis, and treatment of patients with rare diseases through funding research on rare diseases and newborn screening, making available dedicated tools, such as the telemedicine tool, pooling of resources and cooperation.

ALTHEA will develop a web-based platform to facilitate the screening of mental health issues among cancer patients and their families, while supporting patients and healthcare providers in accessing up-to-date educational materials and promoting the delivery of tailored psychological support.

Patients will play a vital role in Health Technology Assessments across the EU when the HTA Regulation ((EU) 2021/2282) comes into force in 2025. Over the past 12 years, The European Patients' Academy on Therapeutic Innovation (EUPATI) has become a key multistakeholder actor for patient...

Background Evidence on the cost effectiveness of deprescribing in multimorbidity is limited. Objective To investigate the cost effectiveness of a general practitioner (GP) delivered, individualised medication review to reduce polypharmacy and potentially inappropriate prescribing in older...

Cross-city patient mobility reflects the geographic mismatch in medical resources, posing significant challenges for healthcare accessibility and equitable resource allocation. However, existing research methods inadequately capture the complex relationships between healthcare supply and demand...

There is a lack of understanding of what may drive gender disparities in healthcare utilization and outcomes. We present novel evidence on the impact of physician-patient gender match on healthcare quality using standardized patients (SPs) in an experiment, and collected interactions between SPs...

Despite growing evidence of gender disparities in healthcare utilization and health outcomes, there is a lack of understanding of what may drive such differences. We present novel evidence on the impact of physician-patient gender match on healthcare quality using the standardized patients (SPs)...

Background: In a world increasingly shaped by technological innovation, the healthcare sector plays an important role in society's sustainable advancement. This study explores the use of IoT and RFID technologies to improve hospital operations and modernize healthcare services. Methods: We...

Cross-border healthcare refers to healthcare received by an individual outside of their Member State of affiliation. EU citizens have the right to receive healthcare in any EU country and to be reimbursed for cross-border care by their home country. To guarantee this fundamental right, the EU...

Using high-quality administrative data from Upper Austria, we analyze the effect of hospital crowding on patients' short- and medium-term healthcare utilization and labor market outcomes. Focusing on acute inpatient diagnoses, we exploit idiosyncratic variation in daily diagnosis-related...

Cross-border healthcare refers to healthcare received by an individual outside of their Member State of affiliation. EU citizens have the right to receive healthcare in any EU country and to be reimbursed for cross-border care by their home country. To guarantee this fundamental right, the EU...

The rapid development of AI solutions reveals opportunities to address the underdiagnosis and poor management of chronic conditions in developing settings. Using the method of simulated patients and experimental designs, we evaluate the quality, safety, and disparity of medical consultation with...

Health care systems rely on geographical boundaries that secure financial stability and adequate planning. Quality differences across regions often arise for efficiency reasons, causing patient flows if mobility is free. In this paper, a theoretical spatial competition model is developed to...

Im Fokus dieser Branchenanalyse stehen die Einflüsse gegenwärtiger globaler Krisen und Transformationstrends auf die Medizintechnikbranche in Deutschland. Anfällige Lieferketten, Unsicherheiten durch Regularien, Globalisierungstendenzen und die Digitalisierung von Produkten und Prozessen...

Objective Studies that examine the broad allocation of resources, regardless of who bears the costs, should ide‑ ally estimate costs from a societal perspective. We have successfully integrated survival rates, employment ratios, and earnings to address the significant challenge of evaluating...

Background Adverse drug events (ADEs) are not only a safety and quality of care issue for patients, but also an eco‑ nomic issue with significant costs. Because they often occur during hospital stays, it is necessary to accurately quantify the costs of ADEs. This review aimed to investigate...

Background There is not yet sufficient scientific evidence to answer the question of the extent to which differ- ent reimbursement systems influence patient care and treatment quality. Due to the asymmetry of information between physicians, health insurers and patients, market-based mechanisms...